Main public logs

Combined display of all available logs of CAMIH. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

• 11:41, 29 August 2024 EProba talk contribs created page Olsen et al. (2001): The effect of aloe vera gel/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy (Created page with "{{Reference |Reference=Publication: The effect of aloe vera gel/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy }} {{Study Note}} =Brief summary= In this study, researchers investigated the effect of an aloe vera gel (100%) on skin reactions in patients undergoing radiotherapy. During radiotherapy, patients were given a mild, unscented soap with which to cleanse their skin. About half of the patients also received th...")
• 11:38, 29 August 2024 EProba talk contribs created page Publication: The effect of aloe vera gel/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy (Created page with "{{Publication |Title=The effect of aloe vera gel/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy |Topic=Aloe vera |Author=Olsen, DL; Raub, W Jr; Bradley, C; Johnson, M; Macias, JL; Love, V; Markoe, A |Year=2001 |Journal=Oncology Nursing Forum |DOI=https://pubmed.ncbi.nlm.nih.gov/11338761/ |Authors Abstract=Purpose/objectives: To determine whether the use of mild soap and aloe vera gel versus mild soap alone would dec...")
• 10:57, 21 August 2024 EProba talk contribs created page Kasseroller et al. (2003): Efficacy and tolerability of proteolytic enzymes as an anti-inflammatory agent in lymphoedema after axillary dissection due to mammary cancer (Created page with "{{Reference |Reference=? }} {{Study Note |Study Note=? }} =Brief summary= This study includes 88 patients with breast cancer. At the start of the study, the patients had already undergone surgery and had their lymph nodes in the breast/armpit area removed. In particular, these patients all suffer from unilateral lymphoedema, which developed after the operation. The patients in this study all receive ‘CDT therapy’, consisting of manual lymph drainage, bandaging of the...")
• 09:45, 21 August 2024 EProba talk contribs created page Kasseroller, R; Wenning, HG (Created page with "{{Author}}")
• 09:44, 21 August 2024 EProba talk contribs created page Publication: Efficacy and tolerability of proteolytic enzymes as an anti-inflammatory agent in lymphoedema after axillary dissection due to mammary cancer (Created page with "{{Publication |Title=Efficacy and tolerability of proteolytic enzymes as an anti-inflammatory agent in lymphoedema after axillary dissection due to mammary cancer |Topic=Enzymes (bromelain papain) |Author=Kasseroller, R; Wenning, HG |Year=2003 |Journal=The European Journal of Lymphology and related problem |DOI=- |Authors Abstract=Aim of the study was to investigate the influence of a proteolytic enzyme, the drug Wobenzym, (Mucos Emulsionsges. mbH, Wien. Austria), on the...")
• 11:13, 15 August 2024 EProba talk contribs created page Wrbka et al. (1987): Unterstützung der Chemotherapie inoperabler Karzinome durch proteolytische Fermente (Created page with "{{Reference |Reference=Publication: Unterstützung der Chemotherapie inoperabler Karzinome durch proteolytische Fermente }} {{Study Note}} =Brief summary= A total of 51 patients with various forms of lung cancer were included in this study. All patients included received the same radiotherapy. However, one arm with 25 patients also received enzyme therapy using klysms. The question of this study is whether this enzyme therapy can positively influence the tolerability of...")
• 10:39, 15 August 2024 EProba talk contribs created page Publication: Unterstützung der Chemotherapie inoperabler Karzinome durch proteolytische Fermente (Created page with "{{Publication |Title=Unterstützung der Chemotherapie inoperabler Karzinome durch proteolytische Fermente |Topic=Enzymes (bromelain papain) |Author=Wrbka, E; Kodras, B |Year=1978 |Journal=Wiener Medizinische Wochenschrift |DOI=? |Authors Abstract=? }}")
• 15:28, 7 August 2024 EProba talk contribs created page Stauder et al. (1991): Strahlentherapeutische Nebenwirkungen bei Abdominalkrebspatienten und deren Reduktion durch hydrolytische Enzyme (Created page with "{{Reference |Reference=Publication: Strahlentherapeutische Nebenwirkungen bei Abdominalkrebspatienten und deren Reduktion durch hydrolytische Enzyme }} {{Study Note |Study Note=? }} =Brief summary= This study includes 68 patients with abdominal cancer who are receiving radiotherapy. One arm of 36 people also received enzyme therapy in tablet form, which was taken during radiotherapy. Another arm of 32 people, on the other hand, received no other therapy or medication apa...")
• 15:21, 7 August 2024 EProba talk contribs created page Publication: Strahlentherapeutische Nebenwirkungen bei Abdominalkrebspatienten und deren Reduktion durch hydrolytische Enzyme (Created page with "{{Publication |Title=Strahlentherapeutische Nebenwirkungen bei Abdominalkrebspatienten und deren Reduktion durch hydrolytische Enzyme |Topic=Enzymes (bromelain papain) |Author=Stauder, G; Beaufort, F; Streichhan, P |Year=1991 |Journal=Deutsche Zeitschrift für Onkologie |DOI=- |Authors Abstract=In dieser randomisierten, prospektiven klinischen Studie wurden additiv eingesetzte hydrolytische Enzyme bei radiationstherapierten Abdominalkrebspatienten mit alleiniger Strahlen...")
• 14:07, 2 August 2024 EProba talk contribs created page Vinzenz et al. (1992): Die Therapie der radiogenen Mukositis mit Enzymen (Created page with "{{Reference |Reference=Publication: Die Therapie der radiogenen Mukositis mit Enzymen }} {{Study Note |Study Note=? }} =Brief summary= This study included 39 people with cancer of the floor of the mouth. All patients received radiotherapy. However, one arm with 19 patients also received enzyme therapy, which was administered in parallel in tablet form. Now the question is whether the additional therapy can positively influence the severity of side effects, such as inflam...")
• 10:54, 31 July 2024 EProba talk contribs created page Publication: Die Therapie der radiogenen Mukositis mit Enzymen (Created page with "{{Publication |Title=Die Therapie der radiogenen Mukositis mit Enzymen |Topic=Enzymes (bromelain papain) |Author=Vinzenz, K; Stauder, U |Year=1992 |Journal=Deutsche Zeitschrift für Onkologie |DOI=https://link.springer.com/chapter/10.1007/978-3-7091-9087-6_34 |Authors Abstract=Die Strahlentherapie stellt eine wirksame Behandlungsvariante der Kopf-Halskarzinome dar. Dies sowohl als Teletherapie (prä- oder postoperativ) als auch in Form der sogenannten Brachytherapie wie...")
• 10:34, 31 July 2024 EProba talk contribs created page Tan et al. (2018): Bromelain has significant clinical benefits after extraction of the third molar during chemotherapy in patients with hematologic tumor (Created page with "{{Reference |Reference=? }} {{Study Note |Study Note=? }} =Brief summary= This study included 72 patients with blood cancer. A common feature of all patients was that their wisdom teeth had been surgically removed to prevent infection during or before chemotherapy. In the patients included, access to the wisdom teeth was more difficult as they were still partially in the bone. One arm of 36 people also received enzyme therapy (bromelain) in tablet form, which was started...")
• 09:01, 31 July 2024 EProba talk contribs created page Tan, Y, Li, P (Created page with "{{Author}}")
• 09:01, 31 July 2024 EProba talk contribs created page Publication: Bromelain has significant clinical benefits after extraction of the third molar during chemotherapy in patients with hematologic tumor (Created page with "{{Publication |Title=Tan (2018): Bromelain has significant clinical benefits after extraction of the third molar during chemotherapy in patients with hematologic tumor |Topic=Enzymes (bromelain papain) |Author=Tan, Y; Li, P |Year=2018 |Journal=Oncology letters |DOI=https://doi.org/10.3892/ol.2017.7673 |Authors Abstract=The purpose of this study was to investigate the application of bromelain in the treatment of pain, swelling, and limited mouth opening in patients with h...")
• 12:35, 30 July 2024 EProba talk contribs created page Martin et al. (2002): Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial (Created page with "{{Reference |Reference=? }} {{Study Note}} =Brief summary= This study included 56 patients with cancer in the pelvic region. These were different types of cancer, but all patients had their tumours completely removed and underwent radiotherapy. Some of the patients (28 people) also received enzyme therapy in tablet form (10mg papain, 40mg trypsin, 40mg chymotrypsin) and some (28 patients) only received a placebo. The question of this study is whether the additional enzym...")
• 11:15, 30 July 2024 EProba talk contribs created page Martin, T, Uhder, K, Kurek, R, Roeddiger, S, Schneider, L, Vogt, HG, Heyd, R, Zamboglou, N (Created page with "{{Author}}")
• 11:14, 30 July 2024 EProba talk contribs created page Publication: Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial (Created page with "{{Publication |Title=Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial |Topic=Enzymes (bromelain papain) |Author=Martin, T; Uhder, K; Kurek, R; Roeddiger, S; Schneider, L; Vogt, HG; Heyd, R; Zamboglou, N. |Year=2002 |Journal=Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology |DOI=https://doi.org/10.1016/S0167-8140(02)00192-5 G...")
• 15:00, 23 July 2024 EProba talk contribs created page Gujral et al. (2001): Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers (Created page with "{{Reference |Reference=Publication: Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers }} {{Study Note}} =Brief summary= This study included 100 patients with head and neck cancer who received radiotherapy. One arm of 53 people also received enzyme therapy in tablet form (10mg papain, 40mg trypsin, 40mg chymotrypsin), which was taken during radiotherapy. A further arm of 47 people, on the other hand,...")
• 14:51, 23 July 2024 EProba talk contribs created page Gujral, MS; Patnaik, PM; Kaul, R; Parikh, HK; Conradt, C; Tamhankar, CP; Daftary, GV (Created page with "{{Author}}")
• 14:50, 23 July 2024 EProba talk contribs created page Publication: Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers (Created page with "{{Publication |Title=Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers |Topic=Enzymes (bromelain papain) |Author=Gujral, MS; Patnaik, PM; Kaul, R; Parikh, HK; Conradt, C; Tamhankar, CP; Daftary, GV |Year=2001 |Journal=Cancer Chemotherapy and Pharmacology |DOI=https://doi.org/10.1007/s002800170005 |Authors Abstract=Purpose: Based on in vitro and on clinical evidence of protection against acute side e...")
• 15:37, 22 July 2024 EProba talk contribs created page Dörr et al. (2007): Efficacy of Wobe-Mugos E for Reduction of Oral Mucositis after Radiotherapy (Created page with "{{Reference |Reference=Publication: Efficacy of Wobe-Mugos E for Reduction of Oral Mucositis after Radiotherapy }} {{Study Note}} =Brief summary= This study included 69 patients with cancer of the mouth and throat who received radiotherapy. One arm of 36 people also received enzyme therapy in tablet form (10mg papain, 40mg trypsin, 40mg chymotrypsin), which was taken during radiotherapy. In contrast, another arm of 33 people received a placebo. The question of this stud...")
• 14:52, 22 July 2024 EProba talk contribs created page Dörr, W; Herrmann, T (Created page with "{{Author}}")
• 14:46, 22 July 2024 EProba talk contribs created page Publication: Efficacy of Wobe-Mugos E for Reduction of Oral Mucositis after Radiotherapy (Created page with "{{Publication |Title=Efficacy of Wobe-Mugos® E for Reduction of Oral Mucositis after Radiotherapy |Topic=Enzymes (bromelain papain) |Author=Dörr, W; Herrmann, T |Year=2007 |Journal=Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft |DOI=https://doi.org/10.1007/s00066-007-1634-0 |Authors Abstract=Purpose: To investigate the efficacy and safety of Wobe-Mugos® E (proteolytic enzymes) for amelioration of early side effects of radiotherapy for head-...")
• 12:07, 6 July 2024 EProba talk contribs created page Dale et al. (2001): Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects (Created page with "{{Reference |Reference=Publication: Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects }} {{Study Note |Study Note=? }} =Brief summary= 120 women with cervical cancer were included in this study. All patients received the same radiotherapy. One group of 60 people also received enzyme therapy in tablet form (10mg papain, 40mg trypsin, 40mg chymotrypsin), which was taken during the radiotherapy. Ano...")
• 11:26, 6 July 2024 EProba talk contribs created page Dale, P. S.; Tamhankar, C. P.; George, D.; Daftary, G. V. (Created page with "{{Author}}")
• 11:25, 6 July 2024 EProba talk contribs created page Publication: Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects (Created page with "{{Publication |Title=Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects |Topic=Enzymes (bromelain papain) |Author=Dale, P. S.; Tamhankar, C. P.; George, D.; Daftary, G. V. |Year=2001 |Journal=Cancer Chemotherapy and Pharmacology |DOI=https://doi.org/10.1007/s002800170006 |Authors Abstract=Purpose: The use of additional therapy with an oral enzyme preparation containing trypsin, chymotrypsin and pa...")
• 08:57, 4 July 2024 EProba talk contribs created page Stendell-Hollis et al. (2010): Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors (Created page with "{{Reference |Reference=Publication: Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors }} {{Study Note |Study Note=? }} =Brief summary= In this study, 54 overweight patients who had survived breast cancer were divided into one of two groups. One group drank 960ml of caffeine-free green tea (including 128.84mg EGCG) daily for 6 months and the control group drank herbal tea. Neither the participants...")
• 08:15, 4 July 2024 EProba talk contribs created page Stendell-Hollis, N. R.; Thomson, C. A.; Thompson, P. A.; Bea, J. W.; Cussler, E. C.; Hakim, I. A. (Created page with "{{Author}}")
• 08:15, 4 July 2024 EProba talk contribs created page Publication: Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors (Created page with "{{Publication |Title=Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors |Topic=Green tea (EGCG) |Author=Stendell-Hollis, N. R.; Thomson, C. A.; Thompson, P. A.; Bea, J. W.; Cussler, E. C.; Hakim, I. A. |Year=2010 |Journal=Journal of human nutrition and dietetics: the official journal of the British Dietetic Association |DOI=https://doi.org/10.1111/j.1365-277X.2010.01078.x |Authors Abstract=Backgrou...")
• 11:40, 30 June 2024 EProba talk contribs created page Nguyen et al. (2012): Randomized, Double-Blind, Placebo-Controlled Trial of Polyphenon E in Prostate Cancer Patients before Prostatectomy: Evaluation of Potential Chemopreventive Activities (Created page with "{{Reference |Reference=Publication: Randomized, Double-Blind, Placebo-Controlled Trial of Polyphenon E in Prostate Cancer Patients before Prostatectomy: Evaluation of Potential Chemopreventive Activities }} =Brief summary= In this study, 50 patients with prostate cancer were randomly assigned to one of two groups. One group took four polyphenon E capsules (totalling 800mg EGCG) every morning, while the other group received a matching placebo. Neither the participants nor...")
• 11:24, 30 June 2024 EProba talk contribs created page Nguyen, M.; Ahmann, F.; Nagle, R.; Hsu, C.-H.; Tangrea, J.; Parnes, H.; Sokoloff, M.; Gretzer, M.; Chow, H.-H. S. (Created page with "{{Author}}")
• 11:23, 30 June 2024 EProba talk contribs created page Publication: Randomized, Double-Blind, Placebo-Controlled Trial of Polyphenon E in Prostate Cancer Patients before Prostatectomy: Evaluation of Potential Chemopreventive Activities (Created page with "{{Publication |Title=Randomized, Double-Blind, Placebo-Controlled Trial of Polyphenon E in Prostate Cancer Patients before Prostatectomy: Evaluation of Potential Chemopreventive Activities |Topic=Green tea (EGCG) |Author=Nguyen, M.; Ahmann, F.; Nagle, R.; Hsu, C.-H.; Tangrea, J.; Parnes, H.; Sokoloff, M.; Gretzer, M.; Chow, H.-H. S. |Year=2012 |Journal=Cancer Prevention Research |DOI=https://doi.org/10.1158/1940-6207.CAPR-11-0306 |Authors Abstract=Compelling preclinical...")
• 19:34, 27 June 2024 EProba talk contribs created page Lian et al. (2014): Comparing the Effectiveness of Green Tea versus Topical Metronidazole Powder in Malodorous Control of Fungating Malignant Wounds in a Controlled Randomised Study (Created page with "{{Reference |Reference=Publication: Comparing the Effectiveness of Green Tea versus Topical Metronidazole Powder in Malodorous Control of Fungating Malignant Wounds in a Controlled Randomised Study }} =Brief summary= In this study, 30 patients with malodorous malignant wounds were randomly assigned to one of two groups. In one group, the wounds were treated daily for 7 days with green tea bags and in the other group with metronidazole powder (= antibiotic in powder form)...")
• 19:06, 27 June 2024 EProba talk contribs created page Lian, S. B.; Xu, Y.; Goh, S. L.; Aw, F. C. (Created page with "{{Author}}")
• 19:06, 27 June 2024 EProba talk contribs created page Publication: Comparing the Effectiveness of Green Tea versus Topical Metronidazole Powder in Malodorous Control of Fungating Malignant Wounds in a Controlled Randomised Stud (Created page with "{{Publication |Title=Comparing the Effectiveness of Green Tea versus Topical Metronidazole Powder in Malodorous Control of Fungating Malignant Wounds in a Controlled Randomised Stud |Topic=Green tea (EGCG) |Author=Lian, S. B.; Xu, Y.; Goh, S. L.; Aw, F. C. |Year=2014 |Journal=Proceedings of Singapore Healthcare |DOI=https://doi.org/10.1177/201010581402300102 |Authors Abstract=Aim: To test the efficacy of green tea with that of conventional topical metronidazole powder by...")
• 10:01, 27 June 2024 EProba talk contribs created page Kessels et al. (2017): Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma A Randomized Clinical Trial (Created page with "{{Reference |Reference=Publication: Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma A Randomized Clinical Trial }} =Brief summary= In this study, 42 patients with superficial basal cell carcinoma were randomly assigned to one of two groups. One group received an ointment containing 55-72mg EGCG per gram, the other group a placebo ointment. Neither the participants nor the study leaders knew whether they were using the ointment with or without th...")
• 09:15, 27 June 2024 EProba talk contribs created page Kessels, J.; Voeten, L.; Nelemans, P.; Cleutjens, J.; Hillen, L. M.; Mosterd, K.; Kelleners-Smeets, N. W. J. (Created page with "{{Author}}")
• 09:14, 27 June 2024 EProba talk contribs created page Publication: Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma: A Randomized Clinical Trial (Created page with "{{Publication |Title=Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma: A Randomized Clinical Trial |Topic=Green tea (EGCG) |Author=Kessels, J.; Voeten, L.; Nelemans, P.; Cleutjens, J.; Hillen, L. M.; Mosterd, K.; Kelleners-Smeets, N. W. J. |Year=2017 |Journal=JAMA dermatology |DOI=https://doi.org/10.1001/jamadermatol.2017.2529 |Authors Abstract=This randomized clinical trial compares topical sinecatechins ointment, 10%, vs. placebo in the treatme...")
• 10:35, 24 June 2024 EProba talk contribs created page Crew et al. (2012): Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer (Created page with "{{Reference |Reference=Publication: Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer }} =Brief summary= In this dose-escalating study, some participants were initially given 400mg EGCG (in the form of polyphenon E capsules) twice a day. As soon as someone reported a severe side effect (grade II according to CTCAE), it was looked at again and calculated how likely it was...")
• 10:22, 24 June 2024 EProba talk contribs created page Crew, K. D.; Brown, P.; Greenlee, H.; Bevers, T. B.; Arun, B.; Hudis, C.; McArthur, H. L.; Chang, J.; Rimawi, M.; Vornik, L.; Cornelison, T. L.; Wang, A.; Hibshoosh, H.; Ahmed, A.; Terry, M. B.; Santella, R. M.; Lippman, S. M.; Hershman, D. L. (Created page with "{{Author}}")
• 10:21, 24 June 2024 EProba talk contribs created page Publication: Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer (Created page with "{{Publication |Title=Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer |Topic=Green tea (EGCG) |Author=Crew, K. D.; Brown, P.; Greenlee, H.; Bevers, T. B.; Arun, B.; Hudis, C.; McArthur, H. L.; Chang, J.; Rimawi, M.; Vornik, L.; Cornelison, T. L.; Wang, A.; Hibshoosh, H.; Ahmed, A.; Terry, M. B.; Santella, R. M.; Lippman, S. M.; Hershman, D. L. |Year=2012 |Journal=Cancer...")
• 13:03, 20 June 2024 EProba talk contribs created page Henning et al. (2015): Randomized Clinical Trial of Brewed Green and Black Tea in Men With Prostate Cancer Prior to Prostatectomy (Created page with "{{Reference |Reference=? }} =Brief summary= In this study, 113 patients with prostate cancer were randomly assigned to one of three groups. One group drank 6 cups of green tea (incl. 562mg EGCG) daily, the second 6 cups of black tea (incl. 28mg EGCG) and the third 6 cups of water as a control group. The participants and study leaders knew whether they had drunk tea or water, as it was not possible to prevent this due to the flavour. The patients drank the tea until the p...")
• 13:00, 20 June 2024 EProba talk contribs created page Henning, S. M.; Wang, P.; Said, J. W.; Huang, M.; Grogan, T.; Elashoff, D.; Carpenter, C. L.; Heber, D.; Aronson, W. J. (Created page with "{{Author}}")
• 12:57, 20 June 2024 EProba talk contribs created page Publication: Randomized Clinical Trial of Brewed Green and Black Tea in Men With Prostate Cancer Prior to Prostatectomy (Created page with "{{Publication |Title=Randomized Clinical Trial of Brewed Green and Black Tea in Men With Prostate Cancer Prior to Prostatectomy |Topic=Green tea (EGCG) |Author=Henning, S. M.; Wang, P.; Said, J. W.; Huang, M.; Grogan, T.; Elashoff, D.; Carpenter, C. L.; Heber, D.; Aronson, W. J. |Year=2015 |Journal=The Prostate |DOI=https://doi.org/10.1002/pros.22943 |Authors Abstract=Background. Preclinical and epidemiologic studies suggest chemopreventive effects of green tea (GT) and...")
• 09:53, 19 June 2024 EProba talk contribs created page Emami et al. (2014): Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of green tea in preventing acute gastrointestinal complications due to radiotherapy (Created page with "{{Reference |Reference=? }} =Brief summary= In this study, 42 patients receiving standardised abdominal or pelvic radiotherapy were randomly assigned to one of two groups. One group received a 450mg green tea tablet and the other group received a placebo tablet, each once daily for 5 weeks. Neither the participants nor the study leaders knew whether they were receiving the tablet with green tea or without the active ingredient. The frequency and severity of diarrhoea and...")
• 09:42, 19 June 2024 EProba talk contribs created page Emami, H., Nikoobin, F., Roayaei, M., Ziya, H. R. (Created page with "{{Author}}")
• 09:38, 19 June 2024 EProba talk contribs created page Publication: Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of green tea in preventing acute gastrointestinal complications due to radiotherapy (Created page with "{{Publication |Title=Publication: Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of green tea in preventing acute gastrointestinal complications due to radiotherapy |Topic=Green tea (EGCG) |Author=Emami, H.; Nikoobin, F.; Roayaei, M.; Ziya, H. R. |Year=2014 |Journal=Journal of Research in Medical Sciences: The official journal of Isfahan University of Medical Sciences |DOI=PMCID: PMC4116577 |Authors Abstract=Background: Radiation-induc...")
• 15:44, 27 May 2024 EProba talk contribs created page Laali et al. (2020): Effect of Selenium on Incidence and Severity of Mucositis during Radiotherapy in Patients with Head and Neck Cancer (Created page with "{{Reference |Reference=Publication: Effect of Selenium on Incidence and Severity of Mucositis during Radiotherapy in Patients with Head and Neck Cancer }} =Brief summary= Purpose: Oral mucositis (OM) is the most frequent side effect of radiation. Selenium deficiency leads to increased levels of free oxygen radicals and the selenium level tends to fall during radiotherapy. Hence, in this double-blind randomised controlled clinical trial, the effect of selenium was assesse...")
• 14:02, 27 May 2024 EProba talk contribs created page Laali, E.; Manifar, S.; Kazemian, A.; Jahangard-Rafsanjani, Z.; Gholami, K. (Created page with "{{Author}}")
• 13:51, 27 May 2024 EProba talk contribs created page Publication: Effect of Selenium on Incidence and Severity of Mucositis during Radiotherapy in Patients with Head and Neck Cancer (Created page with "{{Publication |Title=Publication: Effect of Selenium on Incidence and Severity of Mucositis during Radiotherapy in Patients with Head and Neck Cancer |Topic=Selenium |Author=Laali, E.; Manifar, S.; Kazemian, A.; Jahangard-Rafsanjani, Z.; Gholami, K. |Year=2020 |Journal=Oral Health Prev Dent |DOI=10.3290/j.ohpd.a45080 |Authors Abstract=? }}")